Thu, Oct 23, 2014, 2:35 PM EDT - U.S. Markets close in 1 hr 25 mins

Recent

% | $
Quotes you view appear here for quick access.

Protalix BioTherapeutics, Inc. (PLX) Message Board

  • nuselrami nuselrami Mar 9, 2011 12:32 AM Flag

    Trying to stay cool...

    Difficult days for PLX shareholders but foundementals have not changed.

    hundreds of patients that are threated by the drug are the strongest indication for the big potential we have here...

    European approval if granted will change all the picture.... good news from FDA's meeting will also help...

    If it was so easy it wasn't so rewarding....

    We will go back to 10 in the coming months

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I agree. This is a setback for now but the company will emerge stronger as all the questions about the platform are put to rest. This story was never entirely about one drug for Gaucher's disease. That would have been nice but on approval we will get some of that market based on pricing alone.

      I am long and have been tempted to play the game of getting out and trying to get back in at a lower price. That is so difficult to do. I believe in the company and will hold my shares and add on weakness as appropriate. Nothing has really changed except that the FDA wants more info which means they are taking this NDA very seriously and understands that the approval of this drug has much larger implications for the future of protein synthesis.

 
PLX
2.283-0.017(-0.74%)2:31 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.